Galapagos Says ‘No’ to SpinCo and Instead Will Seek Deals for All Assets
Frank Vinluan , 2025-05-13 18:04:00 Galapagos believed so strongly in its work developing new cancer cell therapies that it pinned its future on them. This past winter, the Belgian drugmaker unveiled a plan to spin out the rest of the company as a standalone business, leaving legacy Galapagos to focus exclusively on its new approach…